Agragene, Inc.

Agragene, Inc. develops innovative biocontrol solutions for agriculture, focusing on enhancing crop productivity through environmentally sustainable methods that minimize chemical usage. Founded in 2017 in San Diego, US, Agragene, Inc. is dedicated to advancing agricultural practices by providing biocontrol solutions.

The company has not undergone significant strategic pivots or changes in operations. Valentino Gantz is the founder, and the current leadership includes CEOs Bryan Witherbee and Gordon Alton. Agragene has raised a total of USD 2. 00 mn in funding across three deals, with the latest Series A funding round completed on March 20, 2023, led by BioGenerator alongside Ospraie Management.

The total amount raised corresponds with the latest round of funding, putting the current company valuation at USD 5. 199 mn. Agragene specializes in innovative biocontrol solutions aimed at enhancing agricultural productivity while maintaining environmental integrity. Central to their offerings is the Precision-Guided Sterile Insect Technology™ (pgSIT)™, which effectively prevents procreation of agricultural pests, thereby safeguarding crop yields.

This technology is designed for various agricultural settings to target common pests threatening food production. Agragene's clean crop protection solutions cater to farmers seeking sustainable alternatives to traditional pesticides, addressing the growing demand for pesticide-free agricultural practices. Their products primarily serve the United States market, with potential applications in other regions. Agragene's revenue model focuses on partnerships and direct sales, providing biological pest control solutions to agricultural producers.

The company establishes long-term partnerships with farmers who invest in advanced pest management systems, incorporating the sterilization technology. These clients benefit from a subscription-based service model, allowing access to ongoing support and the latest advancements in pest control methods. The Precision-Guided Sterile Insect Technology™ (pgSIT)™ is integral to these transactions, aligning with the increasing consumer demand for healthier, chemical-free crops. In March 2023, Agragene, Inc.

raised USD 2. 00 mn in Series A funding, which will be utilized to expand field trials and commercialize eco-friendly alternatives to synthetic pesticides. The company aims to introduce new products designed for effective pest management, targeting markets in both domestic and international regions. The strategic use of recent funding will facilitate these initiatives to enhance agricultural sustainability.